Mikhail V. Semënov
Neurobiology Program
Children's Hospital Boston
61 Binmney Street
Boston
USA
Name/email consistency: high
- LRP5 mutations linked to high bone mass diseases cause reduced LRP5 binding and inhibition by SOST. Semenov, M.V., He, X. J. Biol. Chem. (2006)
- SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor. Semënov, M., Tamai, K., He, X. J. Biol. Chem. (2005)
The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.








